Abiopharma

🔍 Brege Laura (Director)

Company: Pacira BioSciences, Inc. (PCRX)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 6,405 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 30,120.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 10,891 shares of Stock Option (Right to Buy) at $23.42 per share (Derivative)
  Date: 2026-06-10 | Code: A | Expires: 2036-06-10 | Exercise: 2027-06-10 | equity_swap_involved: 0 | shares_owned_after: 10,891.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
• F2: The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date.